与子宫内膜异位症相关的卵巢癌:PI3K/AKT/mTOR途径如何影响它们的发病
Tatiana S Driva1, Christoph Schatz2, Johannes Haybaeck2,3
1First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Biomolecules
|August 26, 2023
概括
在子宫内膜异位症和卵巢癌中mTOR途径的调节失调可能会启动卵巢癌的发展. 这篇评论探讨了子宫内膜,子宫内膜异位症和卵巢癌中的mTOR信号,将其与癌症进展联系起来.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 卵巢清细胞 (OCCC) 和子宫内膜细胞 (EnOC) 癌症被归类为与子宫内膜异位症相关的卵巢癌 (EAOC).
- 在子宫内膜异位症和EAOC中观察到酸丁3-激酶 (PI3K) /蛋白激酶B (AKT) /哺乳动物目标拉巴胺素 (mTOR) 途径的异常激活.
- 在从子宫内膜异位症到卵巢癌的进展中,mTOR途径的确切作用尚未完全理解.
研究的目的:
- 审查关于子宫内膜,子宫内膜异位症和EAOC中的mTOR信号失调的当前知识.
- 阐明PI3K/AKT/mTOR途径与与子宫内膜异位症相关的卵巢癌发展中的其他信号分子之间的相互联系.
主要方法:
- 对mTOR在子宫内膜,子宫内膜异位症和EAOC中的信号传递研究的文献综述.
- 对将PI3K/AKT/mTOR通路变化与卵巢癌中的协同信号联系起来的分子机制的分析.
主要成果:
- 在正常的子宫表皮中,mTOR途径的癌症相关变化可能会发生,可能会通过子宫内膜异位症开始向卵巢癌的进展.
- PI3K/AKT/mTOR通路与子宫内膜异位症和EAOC的病变发生有关.
结论:
- 了解mTOR通路失调对于理解从子宫内膜异位症到卵巢癌的过渡至关重要.
- 对涉及PI3K/AKT/mTOR途径的协同分子机制的进一步研究可能会为EAOC揭示新的治疗点.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:07Oogenesis
63.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.8K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
01:20The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K